BIOX — Bioceres Crop Solutions Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsAdventurousMicro CapContrarian

Annual income statement for Bioceres Crop Solutions, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	R2024 June 30th	R2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	20-F	20-F	20-F	6-K	6-K
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Preliminary	Preliminary
Revenue
Total Revenue	328	415	465	288	238
Cost of Revenue
Gross Profit	120	180	187	103	82.4
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	289	361	419	281	238
Operating Profit	39.9	54.2	45.9	6.6	-0.2
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	14.1	19.1	11.1	-46.5	-51
Provision for Income Taxes
Net Income After Taxes	-3.91	20.2	7.29	-49.1	-54.4
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-7.2	18.8	4.28	-55.2	-230
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-7.2	18.8	4.28	-55.2	-230
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.268	0.291	0.068	-0.703	-0.705